This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Anupam Kumar: Innovator in Cancer Treatment
Introduction
Anupam Kumar is a notable inventor based in Houston, Texas. He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. His work focuses on developing methods and compounds that target specific cancer-related processes.
Latest Patents
Anupam Kumar holds a patent for TG2 inhibitors and their uses. This patent describes methods and compounds for treating cancer, damage resistance, and metastasis. The technology involves inhibiting aberrant TG2 expression and blocking the binding of GTP to TG2. These actions can prevent the induction of epithelial to mesenchymal transition in cancer cells, as well as a stem cell-like phenotype.
Career Highlights
Anupam Kumar is affiliated with the University of Texas System, where he conducts his research. His work has garnered attention for its potential impact on cancer therapies and treatment methodologies.
Collaborations
Some of his notable coworkers include Kapil Mehta and Jansina Fok. Their collaborative efforts contribute to advancing research in cancer treatment and related fields.
Conclusion
Anupam Kumar's innovative work in developing TG2 inhibitors represents a significant advancement in cancer treatment. His contributions to the field highlight the importance of research and collaboration in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile